Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland
| Image |  |
|---|---|
| Description | scientific article published on 05 January 2021 |
| Author/s |
author: Aron Hjalti Bjornsson |
| Publication date | January 5, 2021 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |